dpp4 and glp 1 mechanism of action Cardiovascular effects the DPP-4 inhibitors DPP-4 Inhibitors for Treatment of

Batterham RL, Cohen MA, Ellis SM, le Roux CW, Withers DJ, Frost GS et al

GLP-1s (short for glucagon-like peptide-1 receptor agonists) are medications that mimic a hormone your body already produces in the gut

Ethics declarations Conflict of interest SC received lecture or consultancy fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk

doi: 10.1056/NEJMoa2108269 26

Those taken the high dose had a greater reduction in Hb A1c (1.53% for the 1.5 mg dose, 1.71% for the 3 mg dose and 1.87% for the 4.5 mg dose

Newer glucose-lowering drugs reduce the risk of late-onset seizure and epilepsy: a meta-analysis